Total planned funding: $469,146,397
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $72,834,099 |
Nigeria | $53,527,774 |
South Africa | $46,838,333 |
Zambia | $46,525,365 |
Zimbabwe | $38,458,613 |
Asia Regional Program | $24,871,345 |
Tanzania | $22,739,627 |
West Africa Region | $18,148,918 |
Burundi | $17,723,672 |
Kenya | $16,550,845 |
Vietnam | $16,069,584 |
Ethiopia | $13,229,711 |
Botswana | $11,857,669 |
Haiti | $10,548,100 |
Côte d'Ivoire | $9,008,950 |
Malawi | $8,938,922 |
Democratic Republic of the Congo | $7,301,796 |
Ghana | $6,982,500 |
Dominican Republic | $5,598,850 |
Eswatini | $4,121,942 |
India | $4,050,000 |
South Sudan | $2,868,967 |
Rwanda | $2,594,238 |
Lesotho | $2,292,588 |
Indonesia | $2,075,000 |
Uganda | $1,591,714 |
Namibia | $1,497,275 |
enumerations.Philippines | $300,000 |
Cambodia | $0 |
Organizational Types
NGO | $469,146,397 |
Program Areas
Care | $132,094,847 |
Prevention | $128,247,022 |
Treatment | $123,548,287 |
Testing | $46,728,487 |
Governance and Systems | $38,365,460 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $111,249,106 |
HVOP: Sexual Prevention: Other Sexual Prevention | $82,594,647 |
HKID: Care: Orphans and Vulnerable Children | $81,491,286 |
HVCT: Testing: HIV Testing and Counseling | $46,728,487 |
HBHC: Care: Adult Care and Support | $34,188,868 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $19,362,441 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $17,964,164 |
OHSS: Health Systems Strengthening | $14,892,404 |
HLAB: Laboratory Infrastructure | $12,460,687 |
PDTX: Treatment: Pediatric Treatment | $12,299,181 |
HVSI: Strategic Information | $11,012,369 |
HVTB: Care: TB/HIV | $8,382,361 |
PDCS: Care: Pediatric Care and Support | $8,032,332 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $5,372,465 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,509,828 |
HMIN: Biomedical Prevention: Injection Safety | $299,074 |
HVMS: Management and Operations | $162,294 |
HMBL: Biomedical Prevention: Blood Safety | $144,403 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$469,146,397
View countries